Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +36.87%
#3 Nockchain Nockchain +22.61%
#4 Fabric Protocol Fabric Protocol +19.38%
#5 Bedrock Bedrock +16.78%
#6 Cysic Cysic +15.00%
#7 Perle Perle +12.14%
#8 Tutorial Tutorial +6.24%
#9 Anvil Anvil +6.20%
#10 Arowana Arowana +6.03%
Coin of the day
EXOD EXOD
設定
言語
日本
通貨
USD
テーマ
Idogen AB (publ) Idogen AB (publ)

Idogen AB (publ)

IDOGEN
株式のランク #37811
Idogen AB (publ) is a Swedish biotechnology company specializing in the... Idogen AB (publ) is a Swedish biotechnology company specializing in the development of tolerogenic cell therapies. These innovative treatments are engineered to prevent a patient's immune system from attacking crucial elements, including biological agents, transplanted organs, and the body's own cells or tissues. The company's most advanced product in development is IDO 8, designed for individuals with severe haemophilia A who have developed neutralizing antibodies against their vital coagulation factor VIII treatment. Idogen is also developing IDO T, a tolerogenic cell therapy intended to prevent organ transplant rejection, primarily for kidney transplants, and IDO AID, aimed at treating autoimmune diseases. Established in 2008, the company is headquartered in Lund, Sweden.
株価
$0.01345907
最終同期: 2024-07-12
時価総額
$1.43M
変化（1日）
22.16%
変化（1年）
0.00%
国
SE
取引 Idogen AB (publ) (IDOGEN)

カテゴリー

Healthcare
Idogen AB (publ)（IDOGEN）の株式分割履歴
Idogen AB (publ)株（シンボル：IDOGEN）は合計で0回の株式分割を実施しました。
最新の株式分割はAug 15, 2026に行われました。
Aug 15, 2026より前に購入されたIDOGEN株は、現在0IDOGEN株に相当します。
株式分割一覧
年 株式分割 分割比率 累積分割比率
提供された日付のデータは十分ではありません。
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 0 -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0 -
BE